Upgrade to SI Premium - Free Trial

SurModics (SRDX) PT Raised to $74 at Needham & Company

August 6, 2018 1:44 PM
Needham & Company raised its price target on SurModics (NASDAQ: SRDX) to $74.00 (from $55.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles